Teva

Rediff.com » News » Teva

News for Teva

Business

Indian pharma eyes US gains as $63.7 bn patent cliff nears

The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025–29,......

Teva to sell Ranbaxy drug in US

Ranbaxy Laboratories on Thursday announced that Teva Pharmaceuticals, under a mutual agreement with the Indian pharma major, has commercially launched its Quinapril HCL tablets in the US. The......

Teva opens R&D centre in India

Global pharmaceutical major Teva is planning collaborations with Indian partners for clinical research and biotechnology.Aharon Yaari, president and CEO (API division) of Teva group, said, "India......

Teva to buy Regent Drugs

The government has permitted Teva Pharmaceuticals of Israel and its Dutch subsidiary to together invest $8 million to acquire Regent Drugs from J&K Drugs and Pharmaceuticals.The fresh approval by......

Teva pharma to invest in India

Israel's Teva Pharmaceutical Industries, the world's largest manufacturer of copycat patented drugs (generics), plans to invest over $1 billion in India to acquire Indian drug companies and set up......

Rediffmail for WorkBook a domainRediffmailMoneyOnline ShoppingVideos

Teva

News for Teva

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Teva to sell Ranbaxy drug in US

Teva opens R&D centre in India

Teva to buy Regent Drugs

Teva pharma to invest in India

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS